Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 6/20 | 0.37 |
| ▸ | BRAF | P15056 | 5/20 | 0.35 |
| ▸ | IRAK1 | P51617 | 1/20 | 0.35 |
| ▸ | IRAK4 | Q9NWZ3 | 1/20 | 0.35 |
| ▸ | RAF1 | P04049 | 4/20 | 0.33 |
| ▸ | CCND1 | P24385 | 4/20 | 0.31 |
| ▸ | CDK4 | P11802 | 2/20 | 0.31 |
| ▸ | CDK6 | Q00534 | 3/20 | 0.31 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | TYK2 | P29597 | 1/20 | 0.30 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.30 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.30 |
| ▸ | CDK2 | P24941 | 1/20 | 0.30 |
| ▸ | CCND3 | P30281 | 1/20 | 0.30 |
| ▸ | CDK9 | P50750 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1337981 | 0.95 | SCN9A (0.37) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL4441826 | 0.93 | BRAF (0.38) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL4428496 | 0.93 | SCN9A (0.36) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL394212 | 0.93 | SCN9A (0.38) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL392585 | 0.92 | SCN9A (0.39) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL1339001 | 0.92 | SCN9A (0.37) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL2876430 | 0.92 | SCN9A (0.35) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL1337516 | 0.90 | SCN9A (0.36) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL1338497 | 0.90 | SCN9A (0.36) | SCN9ABRAFIRAK1IRAK4RAF1 | |
| SCHEMBL1338867 | 0.90 | SCN9A (0.36) | SCN9ABRAFIRAK1IRAK4RAF1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2125794-A1 | IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER | Eli Lilly & Company (US) | 2009-12-02 | — | — | EP | disclosed |
| WO-2008076705-A1 | IMIDAZOLIDINONYL AMINOPYRIMIDINE COMPOUNDS FOR THE TREATMENT OF CANCER | ELI LILLY AND COMPANY (US) | 2008-06-26 | — | — | WO | disclosed |